Strategies for Multivessel Revascularization in Patients with Diabetes
Carregando...
Citações na Scopus
1506
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
MASSACHUSETTS MEDICAL SOC
Autores
FARKOUH, Michael E.
DOMANSKI, Michael
SLEEPER, Lynn A.
SIAMI, Flora S.
DANGAS, George
MACK, Michael
YANG, May
COHEN, David J.
ROSENBERG, Yves
SOLOMON, Scott D.
Citação
NEW ENGLAND JOURNAL OF MEDICINE, v.367, n.25, p.2375-2384, 2012
Resumo
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1 +/- 9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in the PCI group and 5.2% in the CABG group (P=0.03). CONCLUSIONS For patients with diabetes and advanced coronary artery disease, CABG was superior to PCI in that it significantly reduced rates of death and myocardial infarction, with a higher rate of stroke. (Funded by the National Heart, Lung, and Blood Institute and others; FREEDOM ClinicalTrials.gov number, NCT00086450.)
Palavras-chave
Referências
- Bypass Angioplasty Revascularization Investigation (BARI) Investigators, 1997, NEW ENGL J MED, V336, P147
- CHESEBRO JH, 1982, NEW ENGL J MED, V307, P1453
- CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401
- Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012
- FERGUSON JJ, 1995, CIRCULATION, V92, P3371
- Fuster V, 2010, CIRCULATION, V121, P2450, DOI 10.1161/CIRCULATIONAHA.109.925867
- Groot MW, 2012, HERZ, V37, P281, DOI 10.1007/s00059-012-3602-4
- Hillis LD, 2011, CIRCULATION, V124, P2610, DOI 10.1161/CIR.0b013e31823b5fee
- Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
- Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
- Lyden P, 1999, STROKE, V30, P2347
- Palmerini T, 2012, J AM COLL CARDIOL, V60, P798, DOI 10.1016/j.jacc.2011.10.912
- RANKIN J, 1957, Scott Med J, V2, P200
- Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
- Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
- Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
- Sianos Georgios, 2005, EuroIntervention, V1, P219
- Smith Sidney C Jr, 2002, Circulation, V105, pe165, DOI 10.1161/01.CIR.0000013957.30622.05
- Alderman EL, 1996, NEW ENGL J MED, V335, P217
- The BARI Investigators, 1997, CIRCULATION, V96, P1761
- Thygesen K, 2012, NAT REV CARDIOL